Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- Xiangpeng Dai
- , Wenjian Gan
- , Xiaoning Li
- , Shangqian Wang
- , Wei Zhang
- , Ling Huang
- , Shengwu Liu
- , Qing Zhong
- , Jianping Guo
- , Jinfang Zhang
- , Ting Chen
- , Kouhei Shimizu
- , Francisco Beca
- , Mirjam Blattner
- , Divya Vasudevan
- , Dennis L Buckley
- , Jun Qi
- , Lorenz Buser
- , Pengda Liu
- , Hiroyuki Inuzuka
- , Andrew H Beck
- , Liewei Wang
- , Peter J Wild
- , Levi A Garraway
- , Mark A Rubin
- , Christopher E Barbieri
- , Kwok-Kin Wong
- , Senthil K Muthuswamy
- , Jiaoti Huang
- , Yu Chen
- , James E Bradner
- , Wenyi Wei
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.